Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients.

ABSTRACT: Adenosine Deaminase (ADA) deficiency is an autosomal recessive variant of severe combined immunodeficiency (SCID) caused by systemic accumulation of ADA substrates. Neurological and behavioral abnormalities observed in ADA-SCID patients surviving after stem cell transplantation or gene therapy represent an unresolved enigma in the field. We found significant neurological and cognitive alterations in untreated ADA-SCID patients as well as in two groups of patients after short- and long-term enzyme replacement therapy with PEG-ADA. These included motor dysfunction, EEG alterations, sensorineural hypoacusia, white matter and ventricular alterations in MRI as well as a low mental development index or IQ. Ada-deficient mice were significantly less active and showed anxiety-like behavior. Molecu

SUBMITTER: Sauer AV 

PROVIDER: S-EPMC5225479 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature